Overview
- 33 inspections across 31 sites are on record.
- 40 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-05.
At a glance
Inspections
33
Sites
31
Observations
40
Career since
Dec 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Exelixis, Inc. | 5 May 2026 | Human Drugs | On file |
| Ty B. Erickson, MD | 26 Mar 2026 | Medical Devices & Rad Health | |
| Vera Therapeutics, Inc. | 2 Mar 2026 | Human Drugs | On file |
| Gilead Sciences, Inc. | 16 Jan 2026 | Human Drugs | |
| Jean Bergeron, MD, MSc, FRCPC | 12 Dec 2025 | Human Drugs | On file |
Sites inspected
Exelixis, Inc.Alameda, United States1 insp.
Ty B. Erickson, MDIdaho Falls, United States1 insp.
Vera Therapeutics, Inc.Brisbane, United States1 insp.
Gilead Sciences, Inc.Foster City, United States1 insp.
Jean Bergeron, MD, MSc, FRCPCQuebec, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Linh Tu4 shared
Dustin R Abaonza4 shared
Kristin M Abaonza2 shared
Korina Serrano1 shared
Humberto Z Gomez1 shared
Stephanie Barragan1 shared
Scott N Lim1 shared
Joan T Briones1 shared
Full investigator report
Get the verbatim findings behind Cynthia J Tsui's 40 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site